Targeted Oncology First Patient With VEGFRi-Associated Hand-Foot Skin Reaction Enrolled in NOVA-II
Newsroom
Clinical Trials Arena I OnQuality enrols first subject in Phase II HFSR therapy trial
Behind Biotech I Hong Tang on Traditional Chinese Medicine and Targeted Cancer Supportive Therapy
Hopkins Biotech Podcast I Hong Tang: Targeting the Common Side Effects of Cancer Therapies
Fierce Biotech I After 3 years away, BIO marked by first-time handshakes
BioSpectrum Asia I Our approach to managing the side effects of cancer therapy has evolved
Podcast: Leading without the Title: Becoming a Natural Leader – with Hong Tang
Informa I Scrip Asks…What Does 2022 Hold For Biopharma? Part 4: Therapeutic Area Advances
GEN | Supportive Care: OnQuality Treats Cancer’s Side Effects
Life Science Leader | The Key To Competitive Differentiation In Life Sciences Is People